STD 13 Panel (Multiplex PCR)

Multiplex STI Detection
Rapid Clinical Results
Sensitive Pathogen Screening

Book Appointment WhatsApp for Details

Results in: 12-24 Hrs

Sample: Urine

Test coverage

Organisms Tested

Herpes Simplex Virus Type 1
Herpes Simplex Virus Type 2
Chlamydia trachomatis
Trichomonas vaginalis
Ureaplasma urealyticum
Mycoplasma hominis
Candida albicans
Neisseria gonorrhoeae
Ureaplasma parvum
Mycoplasma genitalium
Treponema pallidum
Gardnerella vaginalis
Haemophilus ducreyi

What is STD 13 Panel (Multiplex PCR)?

The STD 13 Panel is a comprehensive molecular screening test designed to detect 13 sexually transmitted or genital tract pathogens using advanced PCR technology. This test helps identify common bacterial, viral, fungal and protozoal infections, including infections that may not cause noticeable symptoms. Early detection can help patients receive appropriate medical advice and treatment and reduce the risk of transmission.

Talk to an Expert

Why is this test done?

The STD 13 Panel helps detect infections associated with:

Genital discharge or unusual vaginal discharge.
Burning or pain during urination.
Genital itching or irritation.
Genital sores, blisters or ulcers.
Pelvic discomfort or genital inflammation.
Recurrent or unexplained genital infections.
Possible exposure to sexually transmitted infections.

Who May Consider STD 13 Panel (Multiplex PCR)

Individuals who want comprehensive STI screening.

Individuals who have had unprotected sexual contact.

Individuals with multiple sexual partners.

Individuals whose partner has been diagnosed with an STI.

Individuals experiencing genital itching, unusual discharge, burning urination or irritation.

How STD 13 Panel (Multiplex PCR) Works

Sample Collection

A urine sample or appropriate genital swab is collected according to the laboratory's sample requirements.

Sample Preparation

The collected sample is processed to extract the genetic material (DNA) of the targeted microorganisms.

Multiplex PCR Analysis

Advanced multiplex PCR technology simultaneously detects the DNA of 13 targeted sexually transmitted and genital tract microorganisms in a single test.

Results & Reporting

The results are analysed and reported, indicating which of the 13 targeted microorganisms have been detected, supporting appropriate clinical evaluation and follow-up.